https://www.pharmalive.com/wp-content/uploads/2021/05/U.S.-FDA-approves-Bristol-Myers-bowel-disease-treatment-Reuters-5-27-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-11-06 07:54:342023-11-06 09:22:34Bristol Myers buys Orum's blood cancer therapy for up to $180 mln